Family Medicine · Floral Park, NY
NPI
1558432260
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
26701 Hillside Ave
Floral Park, NY, 11004
Phone (718) 343-7790
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
226 services
Medicare patients, 2024
67
Average age 72
Drug cost, 2024
$4.9M
28,008 prescriptions
Company payments, 2025
$1,055
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed S Qadri was code 99213 (office e&m - established), 140 times for 60 patients. In total Syed S Qadri billed 226 services in 10 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 140 | 60 | $67.74 | $9,484 |
| 36415 Venipuncture Blood Collection | Office | 38 | 31 | $8.65 | $329 |
| 99212 Office E&M - Established | Office | 30 | 23 | $35.23 | $1,057 |
By year: 2022 $20K for 399 services; 2023 $12K for 239 services; 2024 $11K for 226 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 38 | 31 | $8.65 | $329 |
Medicare prescription drug claims, 2024
In 2024, the drug Syed S Qadri prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,014 prescriptions and refills. In total Syed S Qadri wrote 28,008 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,014 | 3,154 | 502 | $12K |
| Metformin Hcl Generic | 1,131 | 1,708 | 268 | $26K |
| Amlodipine Besylate Generic | 1,096 | 1,636 | 275 | $4,439 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 1,086 | 1,301 | 248 | $1,222 |
| Losartan Potassium Generic | 863 | 1,316 | 214 | $4,689 |
| Metoprolol Succinate Generic | 860 | 1,306 | 199 | $7,779 |
| Farxiga Dapagliflozin Propanediol | 769 | 1,028 | 174 | $562K |
| Tamsulosin Hcl Generic | 644 | 958 | 185 | $5,235 |
| Levothyroxine Sodium Generic | 591 | 967 | 144 | $5,213 |
| Famotidine Generic | 501 | 650 | 180 | $2,906 |
| Omeprazole Generic | 454 | 630 | 128 | $3,550 |
| Januvia Sitagliptin Phosphate | 435 | 661 | 99 | $353K |
| Pantoprazole Sodium Generic | 430 | 586 | 143 | $2,419 |
| Simvastatin Generic | 421 | 731 | 105 | $1,943 |
| Glipizide Er Glipizide | 404 | 639 | 113 | $5,756 |
Brand drugs: 4,801 claims; generic drugs: 22,176 claims; opioid claims: 109.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed S Qadri $1,055 ($1,055 in general payments such as food, travel and fees) from 14 companies. The largest payer was Novo Nordisk Inc with $233.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 2 | $233 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $169 |
| Abbvie Inc. ABBV | 4 | $156 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 7 | $118 |
| Kowa Pharmaceuticals America, Inc. | 4 | $77.75 |
| Merck Sharp & Dohme LLC MRK | 2 | $52.59 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $47.03 |
| Pfizer Inc. PFE | 2 | $43.96 |
| Xeris Pharmaceuticals, Inc. | 2 | $41.14 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $40.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.